Abstract:According to numerous animal studies, adverse environmental stimuli, including physical, chemical, and biological factors, can cause low-grade chronic inflammation and subsequent tumor development. Human epidemiological evidence has confirmed the close relationship between chronic inflammation and tumorigenesis. However, the mechanisms driving the development of persistent inflammation toward tumorigenesis remain unclear. In this study, we assess the potential role of reactive oxygen species (ROS) and associated mechanisms in modulating inflammation-induced tumorigenesis. Recent reports have emphasized the cross-talk between oxidative stress and inflammation in many pathological processes. Exposure to carcinogenic environmental hazards may lead to oxidative damage, which further stimulates the infiltration of various types of inflammatory cells. In turn, increased cytokine and chemokine release from inflammatory cells promotes ROS production in chronic lesions, even in the absence of hazardous stimuli. Moreover, ROS not only cause DNA damage but also participate in cell proliferation, differentiation, and apoptosis by modulating several transcription factors and signaling pathways. We summarize how changes in the redox state can trigger the development of chronic inflammatory lesions into tumors. Generally, cancer cells require an appropriate inflammatory microenvironment to support their growth, spread, and metastasis, and ROS may provide the necessary catalyst for inflammation-driven cancer. In conclusion, ROS bridge the gap between chronic inflammation and tumor development; therefore, targeting ROS and inflammation represents a new avenue for the prevention and treatment of cancer.

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

The Role of Redox Environment in Tumors

Mitochondrial Redox Signaling And Tumor Progression

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy

Redox Dysregulation in the Tumor Microenvironment Contributes to Cancer Metastasis.

Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy

Does each Component of Reactive Oxygen Species have a Dual Role in the Tumor Microenvironment?

Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy

The double-edged roles of ROS in cancer prevention and therapy

Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment

Redox regulation of microRNAs in cancer.

Redox Signaling-Mediated Tumor Extracellular Matrix Remodeling: Pleiotropic Regulatory Mechanisms.

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-Regulated Redox Pathway and its Mechanism

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Redox regulation and its emerging roles in cancer treatment

Targeting Metabolic-Redox Circuits for Cancer Therapy

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance

The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context